Rimonabant is a chemical compound that acts as an active pharmaceutical ingredient. It was developed as a selective antagonist for the cannabinoid CB1 receptor and has been investigated for its potential role in weight management and metabolic disorders.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 168273-06-1
Oxymatrine
active pharmaceutical ingredient
2-Oxo Mirabegron
pharmaceutical raw material
Josamycin
pharmaceutical raw material
Fosbretabulin disodium
pharmaceutical raw material
5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide
JZCPYUJPEARBJL-UHFFFAOYSA-N
CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl